A federal judge has ordered long-term care pharmacy company Omnicare to pay almost $949 million in damages and penalties after a jury in April found the company liable for fraudulently dispensing drugs without valid prescriptions to residents of assisted living communities and other non-skilled-nursing residential long-term care facilities.
A spokeswoman for Cincinnati-based Omnicare and its parent company, Woonsocket, RI-based CVS Health, told McKnight’s Senior Living that the companies plan to appeal once the judgment is entered.
The case, United States of America ex rel. Uri Bassan, et al v. Omnicare, Inc., was filed by the federal government in December 2019 and involved more than 3,000 senior living communities across more than 30 states and Washington, DC.
The federal government had alleged that “for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act,” CVS said in a previous filing with the Securities and Exchange Commission. The government alleged that the long-term care pharmacy fraudulently billed federal healthcare programs for “hundreds of thousands” of “stale” or invalid prescriptions for residents in assisted living communities, group homes, independent living communities and other non-skilled residential long-term care facilities.
The jury agreed. The Department of Justice called the verdict “one of the...
Karnataka There are also some allegations by a section of media that there was no student named Ananya at a medical college in Manipal. MANGALURU: Activist Snehamayi Krishna from Mysuru on Thursday...